ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 178 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $501,000 | +615.7% | 7,900 | +217.7% | 0.00% | – |
Q3 2019 | $70,000 | +25.0% | 2,487 | +19.2% | 0.00% | – |
Q2 2019 | $56,000 | +55.6% | 2,087 | +8.0% | 0.00% | – |
Q1 2019 | $36,000 | +63.6% | 1,932 | +5.3% | 0.00% | – |
Q4 2018 | $22,000 | +175.0% | 1,835 | +358.8% | 0.00% | – |
Q3 2018 | $8,000 | +300.0% | 400 | +33.3% | 0.00% | – |
Q2 2018 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | – |
Q1 2018 | $2,000 | +100.0% | 300 | 0.0% | 0.00% | – |
Q4 2017 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
Q3 2017 | $1,000 | – | 300 | 0.0% | 0.00% | – |
Q2 2017 | $0 | – | 300 | 0.0% | 0.00% | – |
Q1 2017 | $0 | – | 300 | 0.0% | 0.00% | – |
Q4 2016 | $0 | -100.0% | 300 | -33.3% | 0.00% | – |
Q3 2016 | $3,000 | +200.0% | 450 | +80.0% | 0.00% | – |
Q2 2016 | $1,000 | – | 250 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |